Intra-Cellular Therapies' Series D Round

Intra-Cellular Therapies raised a round of funding on March 18, 2010.

Intra-Cellular Therapies (ITI) is a biopharmaceutical company that is developing drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). The Company develops compounds t…

Articles about Intra-Cellular Therapies' Series D Round: